Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 2
RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer
The primary objective is to evaluate major pathologic response after RiMO-301 with hypofractionated radiotherapy and a PD-1 inhibitor (pembrolizumab), as asses…
Head and Neck CancerHead CancerNeck Cancer
Estimated
~$10 – $6,250
University of Illinois at ChicagoNCT07732634
Phase 1
A Pilot Study of Neoadjuvant Cemiplimab With Platinum-Doublet Chemotherapy, and Cetuximab in Patients With Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
The purpose of this study is to find out whether combining the standard chemotherapy for head and neck cancer with the immunotherapy drugs cetuximab and cemipl…
Head and Neck CancerHead CancerHead Cancer Neck+3 more
Estimated
~$10 – $6,250
Memorial Sloan Kettering Cancer CenterNCT04722523
Phase 2
A Phase II Study of Pembrolizumab in Combination With Circulating Tumor DNA Response-Adaptive Pulsed Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: The SINERGY Trial (Squamous Cell Carcinoma of Head and Neck Response-Guided Therapy)
By doing this study, the research team would like to learn if using a blood test that measures the amount of tumor DNA in blood can help guide how to use chemo…
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more
Estimated
~$10 – $6,250
University of ChicagoNCT05420948
Observational
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
This study examines the acceptability, feasibility, and safety in developing a prehabilitation program for head and neck cancer patients. The purpose of this r…
Head CancerNeck CancerSarcopenia+1 more
Estimated
~$10 – $6,250
University of California, DavisNCT06722508